038-80laserdiag Selection English 602 PDF

Laser Therapy
BTL THERAPEUTIC ENCYCLOPAEDIA

DENTISTRY
DERMATOLOGY
ENT
GYNAECOLOGY
PAEDIATRICS
REHABILITATION
V602IE31/10/2007
V602IE31/10/2007
dentistry................................................................................................................................................... 6
1.1
alveolitis .......................................................................................................................................... 6
1.2
analgia - haematoma (extraoralis)................................................................................................... 7
1.3
analgia - haematoma (intraoralis).................................................................................................... 8
1.4
analgia - injured nerve..................................................................................................................... 9
1.5
angulus infectiosus........................................................................................................................ 10
1.6
aphta (stomatitis aphtosa) (A) ....................................................................................................... 11
1.7
aphta (stomatitis aphtosa) (B) ....................................................................................................... 12
1.8
caries dentis .................................................................................................................................. 13
1.9
cicatrix cheloidum (A) .................................................................................................................... 14
1.10
cicatrix cheloidum (B) .................................................................................................................... 15
1.11
cicatrix recens (A).......................................................................................................................... 16
1.12
cicatrix recens (B).......................................................................................................................... 17
1.13
contusio......................................................................................................................................... 18
1.14
decubitus....................................................................................................................................... 19
1.15
dentitio difficilis-analgia ................................................................................................................. 20
1.16
fractura analgia........................................................................................................................... 21
1.17
fractura analgia (jaw joint) .......................................................................................................... 22
1.18
gingivitis ........................................................................................................................................ 23
1.19
herpes (A) ..................................................................................................................................... 24
1.20
herpes (B) ..................................................................................................................................... 25
1.21
hyperaemia pulpae........................................................................................................................ 26
1.22
hypersensibilitas dentinalis............................................................................................................ 27
1.23
morbus temporomandibularis (A) .................................................................................................. 28
1.24
morbus temporomandibularis (B) .................................................................................................. 29
1.25
neuralgia nervi trigemini (A) .......................................................................................................... 30
1.26
neuralgia nervi trigemini (B) .......................................................................................................... 31
1.27
parodontitis.................................................................................................................................... 32
1.28
parodontitis (deep periodontal pocket) .......................................................................................... 33
1.29
parodontitis (suppurative gingivitis) ............................................................................................... 34
1.30
periodontitis ................................................................................................................................... 35
1.31
postextractio .................................................................................................................................. 36
1.32
preparatio ...................................................................................................................................... 37
1.33
pulpa aperta .................................................................................................................................. 38
1.34
pulpitis ........................................................................................................................................... 39
1.35
sanatio postoperativa .................................................................................................................... 40
2
dermatology .......................................................................................................................................... 41
2.1
acne .............................................................................................................................................. 41
2.2
alopecia (defluvium capillorum) ..................................................................................................... 42
2.3
2.4
2.5
2.6
2.7
combustio...................................................................................................................................... 47
2.8
decubitus (A) ................................................................................................................................. 48
2.9
decubitus (B) ................................................................................................................................. 49
2.10
dermatitis....................................................................................................................................... 50
2.11
dermatitis perioralis ....................................................................................................................... 51
2.12
eczema.......................................................................................................................................... 52
2.13
furunculus...................................................................................................................................... 53
2.14
haematoma (A) ............................................................................................................................. 54
2.15
haematoma (B) ............................................................................................................................. 55
2.16
herpes (A) ..................................................................................................................................... 56
2.17
herpes (B) ..................................................................................................................................... 57
LASER THERAPY- BTL THERAPEUTIC ENCYCLOP AEDI A | P AGE 2 OF 176
2.18
lichen planus ................................................................................................................................. 58
2.19
rosacea ......................................................................................................................................... 59
2.20
2.21
striae ............................................................................................................................................. 61
2.22
ulcus cruris (B) .............................................................................................................................. 62
3
ENT ........................................................................................................................................................ 63
3.1
3.2
3.3
furunculus...................................................................................................................................... 65
3.4
herpes (A) ..................................................................................................................................... 66
3.5
herpes (B) ..................................................................................................................................... 67
3.6
otitis media acuta (A)..................................................................................................................... 68
3.7
otitis media acuta (B)..................................................................................................................... 69
3.8
otitis media chronica...................................................................................................................... 70
3.9
perforatio membranae tympani traumatici ..................................................................................... 71
3.10
pharyngitis ..................................................................................................................................... 72
3.11
rhinitis vasomotorica...................................................................................................................... 73
3.12
3.13
sinusitis acuta................................................................................................................................ 75
3.14
sinusitis chronica ........................................................................................................................... 76
3.15
tinnitus........................................................................................................................................... 77
3.16
tonsillectomia ................................................................................................................................ 78
3.17
tonsillitis......................................................................................................................................... 79
3.18
tonsillopharyngitis.......................................................................................................................... 80
4
gynaecology.......................................................................................................................................... 81
4.1
abscessus glandulae Bartholini ..................................................................................................... 81
4.2
algomenorrhoea ............................................................................................................................ 82
4.3
cervicitis acuta............................................................................................................................... 83
4.4
cervicitis chronica .......................................................................................................................... 84
4.5
4.6
4.7
4.8
4.9
colpitis acuta ................................................................................................................................. 89
4.10
colpitis chronica............................................................................................................................. 90
4.11
dystrophia vulvae .......................................................................................................................... 91
4.12
haematoma (A) ............................................................................................................................. 92
4.13
haematoma (B) ............................................................................................................................. 93
4.14
herpes genitalis (A) ....................................................................................................................... 94
4.15
herpes genitalis (B) ....................................................................................................................... 95
4.16
incontinentia urinae ....................................................................................................................... 96
4.17
pruritus .......................................................................................................................................... 97
4.18
4.19
striae ............................................................................................................................................. 99
4.20
urocystis-irritabilis........................................................................................................................ 100
4.21
vulvitis ......................................................................................................................................... 101
5
paediatrics........................................................................................................................................... 102
5.1
acne ............................................................................................................................................ 102
5.2
analgia......................................................................................................................................... 103
5.3
aphta (stomatitis aphtosa) (A) ..................................................................................................... 104
5.4
aphta (stomatitis aphtosa) (B) ..................................................................................................... 105
5.5
cicatrix cheloidum (A) .................................................................................................................. 106
5.6
cicatrix cheloidum (B) .................................................................................................................. 107
5.7
cicatrix recens (A)........................................................................................................................ 108
5.8
cicatrix recens (B)........................................................................................................................ 109
5.9
combustio.................................................................................................................................... 110
5.10
contusio (A) ................................................................................................................................. 111
5.11
contusio (B) ................................................................................................................................. 112
5.12
dermatitis..................................................................................................................................... 113
5.13
eczema........................................................................................................................................ 114
5.14
furunculus.................................................................................................................................... 115
5.15
haematoma (A) ........................................................................................................................... 116
5.16
haematoma (B) ........................................................................................................................... 117
5.17
herpes (A) ................................................................................................................................... 118
5.18
herpes (B) ................................................................................................................................... 119
5.19
lichen planus ............................................................................................................................... 120
5.20
oedema (A) ................................................................................................................................. 121
5.21
oedema (B) ................................................................................................................................. 122
5.22
pruritus ........................................................................................................................................ 123
5.23
sanatio postoperativa .................................................................................................................. 124
5.24
striae ........................................................................................................................................... 125
6
rehabilitation ....................................................................................................................................... 126
6.1
achillodynia (A)............................................................................................................................ 126
6.2
achillodynia (B)............................................................................................................................ 127
6.3
arthritis ........................................................................................................................................ 128
6.4
arthritis rheumatica (A) ................................................................................................................ 129
6.5
arthritis rheumatica (B) ................................................................................................................ 130
6.6
arthritis uratica............................................................................................................................. 131
6.7
arthrosis (A)................................................................................................................................. 132
6.8
arthrosis (B)................................................................................................................................. 133
6.9
bursitis (A) ................................................................................................................................... 134
6.10
bursitis (B) ................................................................................................................................... 135
6.11
calcar calcanei (A)....................................................................................................................... 136
6.12
calcar calcanei (B)....................................................................................................................... 137
6.13
chondropathia patellae (A) .......................................................................................................... 138
6.14
chondropathia patellae (B) .......................................................................................................... 139
6.15
contusio (A) ................................................................................................................................. 140
6.16
contusio (B) ................................................................................................................................. 141
6.17
decubitus (A) ............................................................................................................................... 142
6.18
decubitus (B) ............................................................................................................................... 143
6.19
distorsio (A) ................................................................................................................................. 144
6.20
distorsio (B) ................................................................................................................................. 145
6.21
enthesopathia (A) ........................................................................................................................ 146
6.22
enthesopathia (B) ........................................................................................................................ 147
6.23
epicondylitis (A) ........................................................................................................................... 148
6.24
epicondylitis (B) ........................................................................................................................... 149
6.25
induratio penis plastica (A) .......................................................................................................... 150
6.26
induratio penis plastica (B) .......................................................................................................... 151
6.27
ischialgia (A)................................................................................................................................ 152
6.28
ischialgia (B)................................................................................................................................ 153
6.29
morbus Dupuytren (A) ................................................................................................................. 154
6.30
morbus Dupuytren (B) ................................................................................................................. 155
6.31
myorelaxatio (A) .......................................................................................................................... 156
6.32
myorelaxatio (B) .......................................................................................................................... 157
6.33
oedema (A) ................................................................................................................................. 158
6.34
oedema (B) ................................................................................................................................. 159
6.35
sacralgia (A) ................................................................................................................................ 160
6.36
sacralgia (B) ................................................................................................................................ 161
6.37
spina dorsalis (dorsalgia) (A)....................................................................................................... 162
6.38
spina dorsalis (dorsalgia) (B)....................................................................................................... 163
6.39
6.40
6.41
6.42
6.43
6.44
6.45
6.46
6.47
6.48
6.49
6.50
6.51
spondylarthritis ancylopoetica (A) ............................................................................................... 164

spondylarthritis ancylopoetica (B) ............................................................................................... 165
sy. canali carpi (A)....................................................................................................................... 166
sy. canali carpi (B)....................................................................................................................... 167
sy. Tietze (A) ............................................................................................................................... 168
sy. Tietze (B) ............................................................................................................................... 169
sy. vertebralis (A) ........................................................................................................................ 170
sy. vertebralis (B) ........................................................................................................................ 171
tendopathia (A)............................................................................................................................ 172
tendopathia (B)............................................................................................................................ 173
tendovaginitis (A)......................................................................................................................... 174
tendovaginitis (B)......................................................................................................................... 175
tinnitus......................................................................................................................................... 176
1 DENTISTRY
1.1 ALVEOLITIS
DENTISTRY
Program
L-0300
program: L-0300 alveolitis
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Irradiated area: 1 cm2
Frequency: 5 Hz
Duty factor (DF): 80 %
Probe
red
Length of application
according to power of the probe
Frequency of treatments
3x per week
Number of treatments
3-5
Effect
antiphlogistic, biostimulation
(298)
1.2 ANALGIA - HAEMATOMA (EXTRAORALIS)

DENTISTRY
Program
L-0328
program: L-0328 analgia - haematoma (extraoralis)
Therapy parameters
Dosage: 6 J/cm2
Power: by probe
Frequency: 8 Hz
Probe
red
daily
2-6
Effect
analgesic, antiedematous, vasodilatation
Note
If a needle is used that is too large, or anesthesia is injected too quickly, the
blood vessel can be injured and hematoma, oedema and pain may occur in
the site of injection.
(536)
1.3 ANALGIA - HAEMATOMA (INTRAORALIS)

DENTISTRY
Program
L-0327
program: L-0327 analgia - haematoma (intraoralis)
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Frequency: 8 Hz
Probe
red
daily
2-5
Effect
analgesic, antiedematous, vasodilatation
Note
(535)
1.4 ANALGIA - INJURED NERVE

DENTISTRY
Program
L-0329
program: L-0329 analgia - injured nerve
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
red
daily
1-8
Effect
analgesic, biostimulation
Note
(537)
1.5 ANGULUS INFECTIOSUS

DENTISTRY
Program
L-0302
program: L-0302 angulus infectiosus
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
preferably daily, minimum 3 times a week
min. 3 - 5
Effect
biostimulation, antiphlogistic
Note
Irradiate the affected area.

(300)
1.6 APHTA (STOMATITIS APHTOSA) (A)

DENTISTRY
Program
L-0303
program: L-0303 aphta (stomatitis aphtosa) (A)
Therapy parameters
Dosage: 2 J/cm2
Power: by probe
Frequency: Cont.
Duty factor (DF): Cont.
Probe
red
3 - 5 (2x per day possible)
3-6
Effect
Note
Irradiate the entire affected surface.

Part A.
(301)
1.7 APHTA (STOMATITIS APHTOSA) (B)

DENTISTRY
Program
L-0304
program: L-0304 aphta (stomatitis aphtosa) (B)
Therapy parameters
Dosage: 1 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
3-6
Effect
Note

Part B.
(302)
1.8 CARIES DENTIS

DENTISTRY
Program
L-0305
program: L-0305 caries dentis
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
Effect
biostimulation
Note
Prior to extraction or filling, irradiate the dentine in the caries hollow, as well
as the top of the root.
(303)
1.9 CICATRIX CHELOIDUM (A)

DENTISTRY
Program
L-0333
program: L-0333 cicatrix cheloidum (A)
Therapy parameters
Dosage: 4 J/cm2
Power: by probe
Frequency: Cont.
Probe
red
according to power of the probe and size of scar
2 - 4x a week
10 - 40 depending on age of scar, its size and reaction of the treated tissue
Effect
biostimulation, vasodilatation, stimulation of collagen production, increased

vascularization of tissue
Note
Irradiate the whole scar. Effectivity of treatment might decrease with age of
scar.
Part A.
(1038)
1.10 CICATRIX CHELOIDUM (B)

DENTISTRY
Program
L-0306
program: L-0306 cicatrix cheloidum (B)
Therapy parameters
Dosage: 2 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
2 - 4x a week
Effect

Note
scar .
Part B.
(304)
1.11 CICATRIX RECENS (A)

DENTISTRY
Program
L-0307
program: L-0307 cicatrix recens (A)
Therapy parameters
Dosage: 2 J/cm2
Power: by probe
Frequency: Cont.
Probe
red
daily - 3x per week
Effect

Note
scar.
Part A.
(305)
1.12 CICATRIX RECENS (B)

DENTISTRY
Program
L-0308
program: L-0308 cicatrix recens (B)
Therapy parameters
Dosage: 1 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
daily - 3x per week
Effect

Note
scar and its possible hyperpigmentation.
Part B.
(306)
1.13 CONTUSIO
DENTISTRY
Program
L-0309
program: L-0309 contusio
Therapy parameters
Dosage: 12 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
infrared
2 - 4x a week
until disappearance
Effect
analgesic, antiedematous
Note
Contusion is accompanied by a limitation of mouth opening and swelling

above the joint.
(307)
1.14 DECUBITUS
DENTISTRY
Program
L-0310
program: L-0310 decubitus
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
preferably daily
depending on reaction of the treated tissue and depth of necrosis 1 - 5
Effect
biostimulation, antiphlogistic, supports granulation, analgesic
Note
In chronic diseases frequent, preferably daily irradiation can not be avoided.

Irradiate not only margins of decubitus ulcer but cross-hatch the whole area!
After the 1st - 3rd therapy increased pain can occur because of accelerated
regeneration of nerve ends. This worsening should not interrupt the treatment
as it shows a positive body response. For patients with decubitus ulcer after
removable prostheses we reduce pain and enhance healing, in most cases 1
- 3 sessions are sufficient together with prosthesis adjustment.
(308)
1.15 DENTITIO DIFFICILIS-ANALGIA

DENTISTRY
Program
L-0311
program: L-0311 dentitio difficilis-analgia
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
daily
min. 2 - 3, max. 10 - 15
Effect
antiphlogistic, biostimulation, antiedematous, analgesic
Note
This condition is accompanied by considerable pain, inflammatory infiltration

of soft tissues and difficult opening of mouth of certain degree.
(309)
1.16 FRACTURA ANALGIA

DENTISTRY
Program
L-0312
program: L-0312 fractura - analgia
Therapy parameters
Dosage: 6 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
infrared
every other day
5 - 10
Effect
Note
If blood supply to the fragment has not been damaged, the fragment is
repositioned and fixed in situ.
(310)
1.17 FRACTURA ANALGIA (JAW JOINT)

DENTISTRY
Program
L-0330
program: L-0330 fractura analgia (jaw joint)
Therapy parameters
Dosage: 27 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
infrared
3x per week
6 - 12
Effect
antiedematous, analgesic, increased vascularization
Note
If blood supply to the fragment has not been damaged, the fragment is
repositioned and fixed in situ.
(538)
1.18 GINGIVITIS
DENTISTRY
Program
L-0313
program: L-0313 gingivitis
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
depending on purifications
2-4
Effect
biostimulation, analgesic, antiphlogistic
Note
Irradiate 2 4x daily for 2 days prior to cleaning in order to reduce gingival

sensitivity; then remove harmful substances and irradiate again after
cleaning.
(311)
1.19 HERPES (A)

DENTISTRY
Program
L-0314
program: L-0314 herpes (A)
Therapy parameters
Dosage: 2 J/cm2
Power: by probe
Frequency: Cont.
Probe
red
first day 1-2 procedures, then daily
3-8
Effect
biostimulation, antipruritic
Note
Probe: use red light for lips and mucosa, and infrared light for skin. Apply from
the first itching or tension feeling in the tissue.
Part A.
(312)
1.20 HERPES (B)

DENTISTRY
Program
L-0315
program: L-0315 herpes (B)
Therapy parameters
Dosage: 1 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
first day 1-2 procedures, then daily
3-8
Effect
Note
Part B.
(313)
1.21 HYPERAEMIA PULPAE

DENTISTRY
Program
L-0316
program: L-0316 hyperaemia pulpae
Therapy parameters
Dosage: 6 J/cm2
Power: by probe
Frequency: 8 Hz
Probe
red
3x per week
2-6
Effect
biostimulation, analgesic, antiedematous
Note
Laser therapy has analgesic, selective germicidal effect, stimulates

odontoblasts to produce tertiary dentine.
(314)
1.22 HYPERSENSIBILITAS DENTINALIS

DENTISTRY
Program
L-0317
program: L-0317 hypersensibilitas dentinalis
Therapy parameters
Dosage: 6 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
2 - 10
Effect
biostimulation, analgesic, hyperaemic
Note
Irradiate the labial (buccal) side of affected teeth and eventually also oral side
(some specialists recommend irradiation above apex of root).
(315)
1.23 MORBUS TEMPOROMANDIBULARIS (A)

DENTISTRY
Program
L-0334
program: L-0334 morbus temporomandibularis (A)
Therapy parameters
Dosage: 18 J/cm2
Power: by probe
Frequency: Cont.
Probe
infrared
2 - 3x a week
6 - 12 (or until problems subside)
Effect
Note
Exact diagnosis of the cause is essential for maximum effectivity of

treatment.
Part A.
(1039)
1.24 MORBUS TEMPOROMANDIBULARIS (B)

DENTISTRY
Program
L-0318
program: L-0318 morbus temporomandibularis (B)
Therapy parameters
Dosage: 9 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
infrared
2 - 3x a week
Effect
Note
For the best effect of treatment exact identification of problem cause is

needed.
Part B.
(316)
1.25 NEURALGIA NERVI TRIGEMINI (A)

DENTISTRY
Program
L-0335
program: L-0335 neuralgia nervi trigemini (A)
Therapy parameters
Dosage: 12 J/cm2
Power: by probe
Frequency: Cont.
Probe
infrared
3x per week
6 - 10 (or until significant reduction of problems)
Effect
analgesic, inhibition
Note
Exact diagnosis is very important.

Part A.
(1040)
1.26 NEURALGIA NERVI TRIGEMINI (B)

DENTISTRY
Program
L-0319
program: L-0319 neuralgia nervi trigemini (B)
Therapy parameters
Dosage: 6 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
infrared
3x per week
6 - 10 (or until problems decrease significantly)
Effect
analgesic, inhibitive
Note
Exact diagnosis is very important.

Part B.
(317)
1.27 PARODONTITIS
DENTISTRY
Program
L-0320
program: L-0320 parodontitis
Therapy parameters
Dosage: 6 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
daily, minimum 3 times a day
5 - 15
Effect
Note
Periodontal disease is the result of uncontrolled gingivitis.

(318)
1.28 PARODONTITIS (DEEP PERIODONTAL POCKET)

DENTISTRY
Program
L-0332
program: L-0332 parodontitis (deep periodontal pocket)
Therapy parameters
Dosage: 9 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
daily
Effect
Note
Periodontal disease is a result of uncontrolled, progressive gingivitis. In

severe stages or low-response patients combine with infrared beam and dose
18 J/cm2.
(540)
1.29 PARODONTITIS (SUPPURATIVE GINGIVITIS)

DENTISTRY
Program
L-0331
program: L-0331 parodontitis (suppurative gingivitis)
Therapy parameters
Dosage: 6 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
daily, minimum 3 times a day
5 - 15
Effect
Note
Periodontal disease is a result of uncontrolled, progressive gingivitis.

(539)
1.30 PERIODONTITIS
DENTISTRY
Program
L-0321
program: L-0321 periodontitis
Therapy parameters
Dosage: 6 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
daily
2-6
Effect
(319)
1.31 POSTEXTRACTIO
DENTISTRY
Program
L-0322
program: L-0322 postextractio
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
red
1-2
Effect
analgesic, supports healing
Note
Excellent therapeutic results. Laser therapy is recommended as a preventive

measure against post-extraction complications.
(320)
1.32 PREPARATIO
DENTISTRY
Program
L-0323
program: L-0323 preparatio
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
min. 1
Effect
biostimulation
Note
Irradiate cavity and apex of tooth:1. Prior to surgery.

(321)
1.33 PULPA APERTA

DENTISTRY
Program
L-0324
program: L-0324 pulpa aperta
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
red
min. 1
Effect
biostimulation, analgesic
Note
Treatment consists of covering the injured pulp with Ca(OH)2 based

medicaments and laser irradiation which supports healing process in pulp and
relieves pain.
(322)
1.34 PULPITIS
DENTISTRY
Program
L-0325
program: L-0325 pulpitis
Therapy parameters
Dosage: 6 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
red
3x per week
3-6
Effect
analgesic, antiphlogistic
Note
Irradiate the tip of the tooth root.

(323)
1.35 SANATIO POSTOPERATIVA

DENTISTRY
Program
L-0326
program: L-0326 sanatio postoperativa
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
preferably daily, minimum every other day
3-6
Effect
analgesic, germicidal, antiphlogistic, antiedematous
Note
Laser therapy reduces occurrence of post-extraction and post-operative

complications especially in case of difficult and complicated extractions of
wisdom teeth and canine teeth, cystectomies, apicoectomies, at surgical
modifications of the denture bed, at periodontal operations.
(324)
2 DERMATOLOGY
2.1 ACNE
DERMATOLOGY
Program
L-0400
program: L-0400 acne
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
according to power of the probe and extent of affected area
2 - 3x a week
Effect
Note
Irradiate the affected surface.

For severe indurative acne or conglobated acne combine irradiation of
affected places by red and infrared probe in one therapy.
(326)
2.2 ALOPECIA (DEFLUVIUM CAPILLORUM)

DERMATOLOGY
Program
L-0401
program: L-0401 alopecia (defluvium capillorum)
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
2 - 3x a week
depending on severity and reaction of organism to treatment - 8 - 15
Effect
biostimulation
Note
Irradiate scalp where hair is parted. Continue, section by section, until entire
scalp has been treated. Probe must be moving constantly, when applied
stationary reflexive vasoconstriction of arterioles can occur and state can
worsen.
(327)

DERMATOLOGY
Program
L-0420
Therapy parameters
Dosage: 6 J/cm2
Power: by probe
Frequency: Cont.
Probe
red
2 - 4x a week
Effect

Note
Part A.
(1041)

DERMATOLOGY
Program
L-0402
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
2 - 4x a week
Effect

Note
Part B.
(328)

DERMATOLOGY
Program
L-0403
Therapy parameters
Dosage: 4 J/cm2
Power: by probe
Frequency: Cont.
Probe
red
daily 3x per week
5 20 depending on age of scar, its size and reaction of the treated tissue
Effect

Note
Part A.
(329)

DERMATOLOGY
Program
L-0404
Therapy parameters
Dosage: 2 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
daily 3x per week
5 20 depending on age of scar, its size and reaction of the treated tissue
Effect

Note
Part B.
(330)
2.7 COMBUSTIO
DERMATOLOGY
Program
L-0405
program: L-0405 combustio
Therapy parameters
Dosage: 15 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
red
daily 3x per week
10 - 40 depending on severity of burns and reaction of organism to therapy
Effect
biostimulation, antiphlogistic, analgesic, increased vascularization of tissue,

stimulation of collagen production
Note
Irradiation eliminates infection in affected tissue, enhances granulation and

epithelialization, reduces scarring, and prevents keloids from forming.
(331)
2.8 DECUBITUS (A)

DERMATOLOGY
Program
L-0421
program: L-0421 decubitus (A)
Therapy parameters
Dosage: 2 J/cm2
Power: by probe
Frequency: Cont.
Probe
red
depending on reaction of the treated tissue and depth of necrosis 5-20
Effect
biostimulation, antiphlogistic, support of granulation, analgesic
Note

After 1st - 3rd therapy increased pain can occur because of accelerated
as it shows a positive body response.
Part A.
(1042)
2.9 DECUBITUS (B)

DERMATOLOGY
Program
L-0406
program: L-0406 decubitus (B)
Therapy parameters
Dosage: 1 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
Effect
Note

Part B.
(332)
2.10 DERMATITIS
DERMATOLOGY
Program
L-0407
program: L-0407 dermatitis
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
2 - 3x a week
8 - 15 depending on severity of problems and reaction of organism to

treatment
Effect
biostimulation, antiedematous, antiphlogistic
Note
Laser therapy applied at an acute stage (swollen, erythematous and itchy

skin) can have an anti-pruritic effect, allowing treatment with sedatives to be
decreased or eliminated.
(333)
2.11 DERMATITIS PERIORALIS

DERMATOLOGY
Program
L-0408
program: L-0408 dermatitis perioralis
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
according to power of the probe and size of exacerbated area
2 - 3x a week
8 - 15, depending on severity of problems and reaction of organism to

treatment
Effect
Note
This condition is a form of rosacea.

(334)
2.12 ECZEMA
DERMATOLOGY
Program
L-0409
program: L-0409 eczema
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
according to power of the probe and size of exacerbated area
2 - 3x a week

treatment
Effect
biostimulation, antiphlogistic, antiedematous, antipruritic
Note
Causing factors must be identified and eliminated or reduced in order to

prevent recurrence.
(335)
2.13 FURUNCULUS
DERMATOLOGY
Program
L-0410
program: L-0410 furunculus
Therapy parameters
Dosage: 6 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
according to power of the probe, size and depth of furuncle
2 - 3x a week
5 10 (or until problems subside)
Effect
Note
Irradiate affected areas.

(336)
2.14 HAEMATOMA (A)

DERMATOLOGY
Program
L-0422
program: L-0422 haematoma (A)
Therapy parameters
Dosage: 4 J/cm2
Power: by probe
Frequency: Cont.
Probe
red
according to power of the probe, size and depth of hematoma
daily, minimum 3 times a week
4 10 (until hematoma is resorbed)
Effect
analgesic, support of hematoma resorption, increased microcirculation
Note
Start therapy as soon as possible when hematoma occurs.

Part A.
(1043)
2.15 HAEMATOMA (B)

DERMATOLOGY
Program
L-0411
program: L-0411 haematoma (B)
Therapy parameters
Dosage: 2 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
red
Effect
analgesic, supports hematoma resorption, increased microcirculation
Note
Treatment should be started as soon as possible after hematoma occurs.

Part B.
(337)
2.16 HERPES (A)

DERMATOLOGY
Program
L-0412
Therapy parameters
Dosage: 2 J/cm2
Power: by probe
Frequency: Cont.
Probe
red / infrared
1st day 1-2x, then daily
3-8
Effect
Note
Part A.
(338)
2.17 HERPES (B)

DERMATOLOGY
Program
L-0413
Therapy parameters
Dosage: 1 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red / infrared
3-8
Effect
Note
Part B.
(339)
2.18 LICHEN PLANUS

DERMATOLOGY
Program
L-0414
program: L-0414 lichen planus
Therapy parameters
Dosage: 6 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
according to power of the probe and extent of the affected area
2 - 4x a week
Effect
biostimulation, antipruritic, antiedematous
Note
Laser therapy quickly relieves itching and decreases the area of lichen.
(340)
2.19 ROSACEA
DERMATOLOGY
Program
L-0415
program: L-0415 rosacea
Therapy parameters
Dosage: 6 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
3x per week
5 - 10 (or until problems subside, depending on extent and severity of

affection)
Effect
biostimulation, antiphlogistic, antiedematous
Note
There are several forms of rosacea - from occasional red to purely pustular
form.
(341)

DERMATOLOGY
Program
L-0416
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
according to power of the probe and size of post-surgical wound
daily - 3x per week
5 10 depending on reaction of the treated tissue
Effect
biostimulation, antiedematous, vasodilatation, stimulation of collagen

production, increased vascularization of tissue
Note
Accelerates healing of wounds and reduces risk of keloids.

(342)
2.21 STRIAE
DERMATOLOGY
Program
L-0417
program: L-0417 striae
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
according to extent of stretch marks
2 - 3x a week
10 - 30 depending on age of stretch marks and reaction of organism to

therapy
Effect
biostimulation, increased vascularization of tissue, stimulation
Note
The sooner the treatment starts the better the result and the shorter duration
of the therapy.
(343)
2.22 ULCUS CRURIS (B)

DERMATOLOGY
Program
L-0419
program: L-0419 ulcus cruris (B)
Therapy parameters
Dosage: 6 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
according to size and depth of ulcer and power of the probe
minimum daily, if possible 2-3 times a day
Effect
biostimulation, antiphlogistic, increased vascularization, stimulation of

collagen production
Note
Excellent clinical effect. If detritus is present on the surface of decubitus ulcer

combine with infrared beam during one therapy. Irradiate not only margins of
varicose ulcer but cross-hatch the whole area!!!! Combination with infrared
ray with dose 6 J/cm2 is beneficial.
(345)
3 ENT
ENT
Program
L-0600
Therapy parameters
Dosage: 4 J/cm2
Power: by probe
Frequency: Cont.
Probe
red
daily - 3x per week
Effect

Note
Part A.
(367)

ENT
Program
L-0601
Therapy parameters
Dosage: 2 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
daily - 3x per week
Effect

Note
Part B.
(368)
3.3 FURUNCULUS
ENT
Program
L-0602
Therapy parameters
Dosage: 6 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
2 - 3x a week
Effect
Note

(369)
3.4 HERPES (A)

ENT
Program
L-0603
Therapy parameters
Dosage: 2 J/cm2
Power: by probe
Frequency: Cont.
Probe
red / infrared
3-8
Effect
Note
Part A.
(370)
3.5 HERPES (B)

ENT
Program
L-0604
Therapy parameters
Dosage: 1 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red / infrared
3-8
Effect
Note
Part B.
(371)
3.6 OTITIS MEDIA ACUTA (A)

ENT
Program
L-0605
program: L-0605 otitis media acuta (A)
Therapy parameters
Dosage: 4 J/cm2
Power: by probe
Frequency: Cont.
Probe
infrared
daily, at least every other day
35
Effect
antiphlogistic, analgesic
Note
Pain will stop following the first irradiation session, but begin again a few
hours later. Laser therapy must be combined with antibiotics. Laser therapy
can be only applied after paracentesis or spontaneous rupture!!!
Part A.
(372)
3.7 OTITIS MEDIA ACUTA (B)

ENT
Program
L-0606
program: L-0606 otitis media acuta (B)
Therapy parameters
Dosage: 2 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
infrared
daily, at least every other day
35
Effect
Note
Pain will stop following the first irradiation session, but begin again a few
hours later. Laser therapy must be combined with antibiotics. Laser therapy
can be only applied after paracentesis or spontaneous rupture!!!
Part B.
(373)
3.8 OTITIS MEDIA CHRONICA

ENT
Program
L-0607
program: L-0607 otitis media chronica
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
infrared
3x per week (daily when relapse)
36
Effect
Note
For subsequent therapy of chronic conditions irradiate the affected area.

(374)
3.9 PERFORATIO MEMBRANAE TYMPANI TRAUMATICI

ENT
Program
L-0608
program: L-0608 perforatio membranae tympani traumatici
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
every other day
25
Effect
Note
For non-inflamed perforation of the tympanic membrane, apply laser therapy

for 5 - 8 sessions.
(375)
3.10 PHARYNGITIS
ENT
Program
L-0609
program: L-0609 pharyngitis
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
daily - 3x per week
4-8
Effect
antiphlogistic, biostimulation, analgesic
Note
Laser therapy decreases the pain of swallowing, improvement should be

present after the second session.
(376)
3.11 RHINITIS VASOMOTORICA

ENT
Program
L-0610
program: L-0610 rhinitis vasomotorica
Therapy parameters
Dosage: 9 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
infrared
2 - 3x a week
3 10
Effect
Note
Laser therapy brings better results from a rhinoscopy by decreasing edema of

the mucosa and secretion.
(377)

ENT
Program
L-0611
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
daily - 3x per week
5 - 10 depending on reaction of the treated tissue
Effect

Note
Irradiate in disrepairing of lesiones or in failure of healing after surgery.

Regarding increased vasodilatation apply from the 3rd- 4th day after suture.
(378)
3.13 SINUSITIS ACUTA

ENT
Program
L-0613
program: L-0613 sinusitis acuta
Therapy parameters
Dosage: 12 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
infrared
2 - 3x a week
5 10
Effect
biostimulation, antiphlogistic, antiedematous
Note
For acute sinusitis, apply laser therapy on the infraorbital foramen and the
remaining power on the area above the second upper molar. This is a
supportive therapy.
(380)
3.14 SINUSITIS CHRONICA

ENT
Program
L-0614
program: L-0614 sinusitis chronica
Therapy parameters
Dosage: 6 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
infrared
2 - 3x a week
5 10
Effect
Note
For acute sinusitis, apply laser therapy with power of 12 J/cm2 on the
infraorbital foramen and the remaining power on the area above the second
upper molar.
(381)
3.15 TINNITUS
ENT
Program
L-0616
program: L-0616 tinnitus
Therapy parameters
Dosage: 135 J/cm2

Power: by probe
Frequency: 5 Hz
Probe
infrared
2 - 3x a week
6 - 12
Effect
biostimulation
Note
Unusually high dose is needed for sufficient effect as 98% of irradiated

energy is absorbed in petrous bone! Apply to mastoid processus towards the
contralateral orbit. If auditory canal is irradiated directly, dose of 75 J/cm2 is
satisfactory. Combine treatment with manipulative therapy of the spine.
Part B.
(383)
3.16 TONSILLECTOMIA
ENT
Program
L-0617
program: L-0617 tonsillectomia
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
red
daily
3-5
Effect
inhibitive, analgesic
Note
Apply laser light with special optical attachment as soon as possible after
tonsillectomy.
(384)
3.17 TONSILLITIS
ENT
Program
L-0618
program: L-0618 tonsillitis
Therapy parameters
Dosage: 15 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red / infrared
daily - 3x per week
4 10
Effect
Note
Irradiate with red probe tonsils directly or apply infrared laser light through the
surface of submandibular region.
(385)
3.18 TONSILLOPHARYNGITIS
ENT
Program
L-0619
program: L-0619 tonsillopharyngitis
Therapy parameters
Dosage: 15 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red / infrared
daily - 3x per week
4-8
Effect
Note
Positive results occur after 2 sessions.

(386)
4 GYNAECOLOGY
4.1 ABSCESSUS GLANDULAE BARTHOLINI
GYNAECOLOGY
Program
L-0500
program: L-0500 abscessus glandulae Bartholini
Therapy parameters
Dosage: 9 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
5 - 15
Effect
biostimulation, analgesic, antiphlogistic
Note
At acute inflammation in the initial stage irradiate place of erythema.

(347)
4.2 ALGOMENORRHOEA
GYNAECOLOGY
Program
L-0501
program: L-0501 algomenorrhoea
Therapy parameters
Dosage: 6 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
red / infrared
2 - 3x a week
10 - 15
Effect
analgesic, myorelaxation
Note
Start irradiating one week before menstruation. Apply red beam using proper
optical extension intra-vaginally. Apply infrared beam bilaterally to SI joint and
sacral promontory.
(348)
4.3 CERVICITIS ACUTA

GYNAECOLOGY
Program
L-0502
program: L-0502 cervicitis acuta
Therapy parameters
Dosage: 6 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
red
every other day
Effect
Note
Irradiate by using gynecological specula with special gynecological optical

attachment.
(349)
4.4 CERVICITIS CHRONICA

GYNAECOLOGY
Program
L-0503
program: L-0503 cervicitis chronica
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
red
every other day
Effect
Note
Irradiate by using gynecological specula with special gynecological optical

attachment.
(350)

GYNAECOLOGY
Program
L-0523
Therapy parameters
Dosage: 0.7 J/cm2

Power: by probe
Frequency: Cont.
Probe
red
2 - 4 times a week
Effect
biostimulation, stimulation of collagen production, increased vascularization of

tissue
Note
Irradiate the whole scar.

Part A.
(1044)

GYNAECOLOGY
Program
L-0504
Therapy parameters
Dosage: 0.3 J/cm2

Power: by probe
Frequency: 5 Hz
Probe
red
2 - 4x a week
Effect

tissue
Note

Part B.
(351)

GYNAECOLOGY
Program
L-0524
Therapy parameters
Dosage: 0.7 J/cm2

Power: by probe
Frequency: Cont.
Probe
red
2 - 4x a week
Effect
biostimulation, stimulation of collagen production, increased vascularization

of tissue
Note

Part A.
(1045)

GYNAECOLOGY
Program
L-0505
Therapy parameters
Dosage: 0.3 J/cm2

Power: by probe
Frequency: 5 Hz
Probe
red
2 - 4x a week
Effect

tissue
Note

Part B.
(352)
4.9 COLPITIS ACUTA

GYNAECOLOGY
Program
L-0507
program: L-0507 colpitis acuta
Therapy parameters
Dosage: 6 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
red
every other day
Effect
Note
Irradiate by maximum dilatation of gynecological specula first in horizontal

and second in vertical position.
(353)
4.10 COLPITIS CHRONICA

GYNAECOLOGY
Program
L-0508
program: L-0508 colpitis chronica
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
red
every other day
Effect
Note
Irradiate by maximum dilatation of gynecological specula first in horizontal

and second in vertical position.
(354)
4.11 DYSTROPHIA VULVAE

GYNAECOLOGY
Program
L-0511
program: L-0511 dystrophia vulvae
Therapy parameters
Dosage: 4 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
red
1st week daily, then 2 - 3 per week
5 15
Note
Directly irradiate the affected area.

(356)
4.12 HAEMATOMA (A)

GYNAECOLOGY
Program
L-0525
Therapy parameters
Dosage: 2 J/cm2
Power: by probe
Frequency: Cont.
Probe
red
Effect
Note
Start therapy as soon as possible when hematoma occurs.

Part A.
(1046)
4.13 HAEMATOMA (B)

GYNAECOLOGY
Program
L-0513
Therapy parameters
Dosage: 1 J/cm2
Power: by probe
Frequency: 8 Hz
Probe
red
Effect
Note
Treatment should be started as soon as possible after hematoma occurs.

Part B.
(357)
4.14 HERPES GENITALIS (A)

GYNAECOLOGY
Program
L-0526
program: L-0526 herpes genitalis (A)
Therapy parameters
Dosage: 2 J/cm2
Power: by probe
Frequency: Cont.
Probe
red
according to power of the probe and extent of herpes
Effect
Note
Irradiate at the first signs of tension or itching in the tissue.

Part A.
(1047)
4.15 HERPES GENITALIS (B)

GYNAECOLOGY
Program
L-0514
program: L-0514 herpes genitalis (B)
Therapy parameters
Dosage: 1 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
according to power of the probe and extent of herpes
Effect
Note
Irradiate at the first signs of tension or itching in the tissue.

Part B.
(358)
4.16 INCONTINENTIA URINAE

GYNAECOLOGY
Program
L-0516
program: L-0516 incontinentia urinae
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
red
6 - 12
Effect
analgesic, antiedematous, antiphlogistic
Note
Irradiate direct suture of surgical field, irradiate vagina in area of trigonum of

urinary bladder. Therapy should be started immediately or as soon as
possible after the surgery.
(359)
4.17 PRURITUS
GYNAECOLOGY
Program
L-0518
program: L-0518 pruritus
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
red
1st week every day, than 2-3 per week
3 10
Effect
inhibitive, antiedematous
Note
Irradiate all area from 1 cm distance from surface skin.

(361)

GYNAECOLOGY
Program
L-0519
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
according to power of the probe and size of postsurgical wound
daily, in first two days possibly twice a day
Effect

Note
Shortens wound healing and reduces keloid formation. Therapy should be

started immediately or as soon as possible after the surgery.
(362)
4.19 STRIAE
GYNAECOLOGY
Program
L-0520
Therapy parameters
Dosage: 1 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
2 - 3x a week

therapy
Effect
biostimulation, increased vascularization of tissue, stimulation of collagen

production
Note
Results are better and therapy shorter when started in early stages of the
condition.
(363)
4.20 UROCYSTIS-IRRITABILIS
GYNAECOLOGY
Program
L-0521
program: L-0521 urocystis-irritabilis
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
red
6 12
Effect
inhibitive
Note
Irradiate the anterior vaginal wall and supplement with point irradiation of
sacrum excavation.
(364)
4.21 VULVITIS
GYNAECOLOGY
Program
L-0522
program: L-0522 vulvitis
Therapy parameters
Dosage: 12 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
red
4 - 8 (or after problems subside)
Effect
Note
Irradiate affected area directly or in cavity with intra-vaginal optical extention.

For more severe stages of disease or slow subsidence of problems use
infrared beam and dose 9 - 12 J/cm2.
(365)
5 PAEDIATRICS
5.1 ACNE
PAEDIATRICS
Program
L-1100
program: L-1100 acne
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
2 - 3x a week
Effect
Note
Irradiate the affected surface.

For severe indurative acne or conglobated acne combine irradiation of
affected places by red and infrared probe in one therapy.
(475)
5.2 ANALGIA
PAEDIATRICS
Program
L-1101
program: L-1101 analgia
Therapy parameters
Dosage: 4 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
infrared
daily
Note
Irradiate trigger points.

(476)
5.3 APHTA (STOMATITIS APHTOSA) (A)

PAEDIATRICS
Program
L-1102
program: L-1102 aphta (stomatitis aphtosa) (A)
Therapy parameters
Dosage: 2 J/cm2
Power: by probe
Frequency: Cont.
Probe
red
3-6
Effect
Note

Part A.
(477)
5.4 APHTA (STOMATITIS APHTOSA) (B)

PAEDIATRICS
Program
L-1103
program: L-1103 aphta (stomatitis aphtosa) (B)
Therapy parameters
Dosage: 1 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
3-6
Effect
Note

Part B.
(478)

PAEDIATRICS
Program
L-1120
Therapy parameters
Dosage: 6 J/cm2
Power: by probe
Frequency: Cont.
Probe
red
2 - 4x a week
Effect

Note
Part A.
(1072)

PAEDIATRICS
Program
L-1104
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
2 - 4x a week
Effect

Note
Part B.
(479)

PAEDIATRICS
Program
L-1105
Therapy parameters
Dosage: 4 J/cm2
Power: by probe
Frequency: Cont.
Probe
red
daily 3x per week
Effect
biostimulating, vasodilatation, stimulation of collagen production, increased

Note
Part A.
(480)

PAEDIATRICS
Program
L-1106
Therapy parameters
Dosage: 2 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
daily 3x per week
Effect

Note
Part B.
(481)
5.9 COMBUSTIO
PAEDIATRICS
Program
L-1107
program: L-1107 combustio
Therapy parameters
Dosage: 15 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
red
daily 3x per week
10 - 40 depending on severity of burns and reaction of organism to therapy
Effect
biostimulation, antiphlogistic, analgesic, increased vascularization of tissue,

stimulation of collagen production
Note
Irradiation eliminates infection in the affected tissue, enhances granulation

and epithelialization, reduces scarring, and prevents keloids from forming.
(482)
5.10 CONTUSIO (A)

PAEDIATRICS
Program
L-1121
program: L-1121 contusio (A)
Therapy parameters
Dosage: 8 J/cm2
Power: by probe
Frequency: Cont.
Probe
infrared
5x per week
5 10
Effect
analgesic, antiedematous, biostimulation
Note
Irradiate as soon as possible after injury, which hastens analgesic effect,

prevents edema and absorbs a hematoma.
Part A.
(1073)
5.11 CONTUSIO (B)

PAEDIATRICS
Program
L-1108
program: L-1108 contusio (B)
Therapy parameters
Dosage: 4 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
infrared
5x per week
5 10
Effect
Note

prevents edema and absorb a hematoma.
Part B.
(483)
5.12 DERMATITIS
PAEDIATRICS
Program
L-1109
program: L-1109 dermatitis
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
2 - 3x a week

treatment
Effect
Note
Laser therapy applied at an acute stage (swollen and itchy skin) can have an
anti-pruriginous effect, allowing treatment with sedatives to be decreased or
eliminated.
(484)
5.13 ECZEMA
PAEDIATRICS
Program
L-1110
program: L-1110 eczema
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
according to power of the probe and size of the exacerbated area
2 - 3x a week

treatment
Effect
biostimulation, antiedematous, antiphlogistic, antipruritic
Note
It is necessary to identify and eliminate or reduce the inducing factor,

otherwise the troubles will recur.
(485)
5.14 FURUNCULUS
PAEDIATRICS
Program
L-1111
Therapy parameters
Dosage: 6 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
2 - 3x a week
Effect
Note

(486)
5.15 HAEMATOMA (A)

PAEDIATRICS
Program
L-1122
Therapy parameters
Dosage: 4 J/cm2
Power: by probe
Frequency: Cont.
Probe
red
4 - 10 (until hematoma is resorbed)
Effect
Note
Treatment should be started as soon as possible after hematoma occurence.

For hematoma in mucosa use dose 3 J/cm2.
Part A.
(1074)
5.16 HAEMATOMA (B)

PAEDIATRICS
Program
L-1112
Therapy parameters
Dosage: 2 J/cm2
Power: by probe
Frequency: 8 Hz
Probe
red
Effect
Note
Treatment should be started as soon as possible after hematoma occurs. For

hematoma in mucosa use dose 3 J/cm2.
Part B.
(487)
5.17 HERPES (A)

PAEDIATRICS
Program
L-1113
Therapy parameters
Dosage: 2 J/cm2
Power: by probe
Frequency: Cont.
Probe
red / infrared
3-8
Effect
Note
Part A.
(488)
5.18 HERPES (B)

PAEDIATRICS
Program
L-1114
Therapy parameters
Dosage: 1 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red / infrared
3-8
Effect
Note
Part B.
(489)
5.19 LICHEN PLANUS

PAEDIATRICS
Program
L-1115
program: L-1115 lichen planus
Therapy parameters
Dosage: 6 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
2 - 4x a week
5 10 (until problems subside)
Effect
biostimulation, antipruritic, antiedematous
Note
Laser therapy quickly relieves itching and decreases the area of lichen.
(490)
5.20 OEDEMA (A)

PAEDIATRICS
Program
L-1123
program: L-1123 oedema (A)
Therapy parameters
Dosage: 18 J/cm2
Power: by probe
Frequency: Cont.
Probe
infrared
according to extent of oedema and power of the probe
3 - 5x a week
5 15
Effect
antiedematous, vasodilatation, increased vascularization
Note
Irradiate the affected areas.

Increase dose with increased depth of oedema.
Part A.
(1075)
5.21 OEDEMA (B)

PAEDIATRICS
Program
L-1116
program: L-1116 oedema (B)
Therapy parameters
Dosage: 9 J/cm2
Power: by probe
Frequency: 8 Hz
Probe
infrared
3 - 5x a week
5 15
Effect
Note

Part B.
(491)
5.22 PRURITUS
PAEDIATRICS
Program
L-1117
program: L-1117 pruritus
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
red
1st week every day, than 2-3 per week
3 10
Effect
inhibitive, antiedematous
Note
Irradiate the whole area from 1 cm distance from surface skin.

(492)

PAEDIATRICS
Program
L-1118
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
daily 3x per week
Effect

Note
Accelerates healing of wounds and reduces risk of keloids.

(493)
5.24 STRIAE
PAEDIATRICS
Program
L-1119
Therapy parameters
Dosage: 3 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
2 3 a week

therapy
Effect
biostimulation, increased tissue vascularization, stimulation
Note
The sooner the treatment starts the better the result and the shorter duration
of treatment.
(494)
6 REHABILITATION
6.1 ACHILLODYNIA (A)
REHABILITATION
Program
L-0700
program: L-0700 achillodynia (A)
Therapy parameters
Dosage: 20 J/cm2
Power: by probe
Frequency: Cont.
Probe
infrared
2 - 3x a week
8 - 10 (min. 5)
Effect
biostimulation, vasodilatation, analgesic, antiedematous
Note
Irradiate as in post-surgical states. First 2-3 days after trauma infrared laser
with 5 Hz frequency can be applied. After laser application there is often a
fast subsidence of pain and oedema. However it is essential to instruct the
patient that the joint is not healed in minimum 6 weeks after problems occur
and that he must follow rest regime together with physiotherapy, eventually
other physical therapy.
Part A.
(388)
6.2 ACHILLODYNIA (B)

REHABILITATION
Program
L-0701
program: L-0701 achillodynia (B)
Therapy parameters
Dosage: 10 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
infrared
2 - 3x a week
8 - 10 (min. 5)
Effect
biostimulation, vasodilatation, analgesic, antiedematous
Note
Irradiate as in post-surgical states. First 2-3 days after trauma infrared laser
with 5 Hz frequency can be applied. After laser application there is often a
fast subsidence of pain and oedema. However it is essential to instruct the
patient that the joint is not healed in minimum 6 weeks after problems occur
and that he must follow rest regime together with physiotherapy, eventually
Part B.
(389)
6.3 ARTHRITIS
REHABILITATION
Program
L-0702
program: L-0702 arthritis
Therapy parameters
Dosage: 9 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
infrared
2 - 3x a week
10 - 15
Effect
Note
Laser therapy can also be used for all joints affected by rheumatoid diseases.
Given dose is designed for small peripheral joints. For joints in greater depth
increase dose respectively.
(390)
6.4 ARTHRITIS RHEUMATICA (A)

REHABILITATION
Program
L-0703
program: L-0703 arthritis rheumatica (A)
Therapy parameters
Dosage: 18 J/cm2
Power: by probe
Frequency: Cont.
Probe
infrared
2 - 3x a week
10 - 15
Effect
Note
Part A.
(391)
6.5 ARTHRITIS RHEUMATICA (B)

REHABILITATION
Program
L-0704
program: L-0704 arthritis rheumatica (B)
Therapy parameters
Dosage: 9 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
infrared
2 - 3x a week
10 - 15
Effect
Note
Part B.
(392)
6.6 ARTHRITIS URATICA

REHABILITATION
Program
L-0705
program: L-0705 arthritis uratica
Therapy parameters
Dosage: 30 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
infrared
daily
Effect
tranquilizing, analgesic, antiedematous
Note
In acute stadium irradiate directly to the places of inflammation of joint. This is

a supportive therapy, medicamental therapy and mainly strict compliance with
dietary regime are essential.
(393)
6.7 ARTHROSIS (A)

REHABILITATION
Program
L-0706
program: L-0706 arthrosis (A)
Therapy parameters
Dosage: 20 J/cm2
Power: by probe
Frequency: Cont.
Probe
infrared
2 - 3x a week
min. 10 (or until problems are reduced significantly)
Effect
analgesic, antiedematous, myorelaxation
Note
Irradiate affected joint structure (Laser acupuncture can be used for trigger
and acupuncture points, hyperalgesic zones, paravertebral points, as well as
acupuncture points on the ear. Density: 1.0 - 3.0 J/cm2). If no effect is present
after the 3rd therapy, increase dose with respect to depth of affected joint.
Part A.
(394)
6.8 ARTHROSIS (B)

REHABILITATION
Program
L-0707
program: L-0707 arthrosis (B)
Therapy parameters
Dosage: 10 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
infrared
2 - 3x a week
min. 10 (or until problems are reduced significantly)
Effect
analgesic, antiedematous, myorelaxation
Note
Irradiate affected joint structure (Laser acupuncture can be used for trigger
and acupuncture points, hyperalgesic zones, paravertebral points, as well as
acupuncture points on the ear. Density: 1.0 - 3.0 J/cm2). If no effect is present
after the 3rd therapy, increase dose with respect to depth of affected joint.
Part B.
(395)
6.9 BURSITIS (A)

REHABILITATION
Program
L-0708
program: L-0708 bursitis (A)
Therapy parameters
Dosage: 18 J/cm2
Power: by probe
Frequency: Cont.
Probe
infrared
2 - 3x a week
4 16
Effect
analgesic, biostimulation, antiphlogistic
Note

If no satisfactory effect is present after the 3rd therapy, increase dose with
respect to depth of affected joint.
Part A.
(396)
6.10 BURSITIS (B)

REHABILITATION
Program
L-0709
program: L-0709 bursitis (B)
Therapy parameters
Dosage: 9 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
infrared
2 - 3x a week
4 16
Effect
analgesic, biostimulation, antiphlogistic
Note

If no satisfactory effect is present after the 3rd therapy, increase dose with
respect to depth of affected joint.
Part B.
(397)
6.11 CALCAR CALCANEI (A)

REHABILITATION
Program
L-0710
program: L-0710 calcar calcanei (A)
Therapy parameters
Dosage: 20 J/cm2
Power: by probe
Frequency: Cont.
Probe
infrared
2 - 3x a week
6 10
Effect
analgesic
Note
Laser therapy is effective even in torpid states.

Before start of laser therapy make sure that the patient undergoes pedicure.
Thin skin barrier improves laser beam penetration.
Part A.
(398)
6.12 CALCAR CALCANEI (B)

REHABILITATION
Program
L-0711
program: L-0711 calcar calcanei (B)
Therapy parameters
Dosage: 10 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
infrared
2 - 3x a week
6 10
Effect
analgesic
Note
Laser therapy is effective even in torpid states.

Before start of laser therapy make sure that patient undergoes pedicure. Thin
skin barrier improves laser beam penetration.
Part B.
(399)
6.13 CHONDROPATHIA PATELLAE (A)

REHABILITATION
Program
L-0744
program: L-0744 chondropathia patellae (A)
Therapy parameters
Dosage: 14 J/cm2
Power: by probe
Frequency: Cont.
Probe
infrared
2 - 3x a week
5 10 or until problems subside
Effect
analgesic, antiedematous, increased vascularization of tissue
Note

Part A.
(1052)
6.14 CHONDROPATHIA PATELLAE (B)

REHABILITATION
Program
L-0718
program: L-0718 chondropathia patellae (B)
Therapy parameters
Dosage: 7 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
infrared
2 - 3x a week
5 10 or until problems subside
Effect
analgesic, antiedematous, increased vascularization of tissue
Note

Part B.
(406)
6.15 CONTUSIO (A)

REHABILITATION
Program
L-0752
program: L-0752 contusio (A)
Therapy parameters
Dosage: 8 J/cm2
Power: by probe
Frequency: Cont.
Probe
infrared
5x per week
5 10
Effect
Note

prevents edema and to absorb a hematoma.
Part A.
(1048)
6.16 CONTUSIO (B)

REHABILITATION
Program
L-0712
program: L-0712 contusio (B)
Therapy parameters
Dosage: 4 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
infrared
5x per week
5 10
Effect
Note

prevents edema and to absorb a hematoma.
Part B.
(400)
6.17 DECUBITUS (A)

REHABILITATION
Program
L-0741
program: L-0741 decubitus (A)
Therapy parameters
Dosage: 2 J/cm2
Power: by probe
Frequency: Cont.
Probe
red
Effect
Note

Part A.
(1049)
6.18 DECUBITUS (B)

REHABILITATION
Program
L-0713
program: L-0713 decubitus (B)
Therapy parameters
Dosage: 1 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
red
depending on reaction of the treated tissue and depth of necrosis 5 - 20
Effect
Note

Part B.
(401)
6.19 DISTORSIO (A)

REHABILITATION
Program
L-0742
program: L-0742 distorsio (A)
Therapy parameters
Dosage: 18 J/cm2
Power: by probe
Frequency: Cont.
Probe
infrared
6 - 10
Effect
Note
Apply laser therapy as soon as possible. It is essential to instruct the patient

that although pain subsides rapidly, the joint is not fully healed in minimum 6
weeks and that he must follow rest regime together with physiotherapy.
Part A.
(1050)
6.20 DISTORSIO (B)

REHABILITATION
Program
L-0714
program: L-0714 distorsio (B)
Therapy parameters
Dosage: 9 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
infrared
optimum daily, minimum 3 times a week
6 - 10
Effect
Note
Apply laser therapy as soon as possible. It is essential to instruct the patient

that although pain subsides rapidly, the joint is not fully healed in minimum 6
weeks and that he must follow rest regime together with physiotherapy.
Part B.
(402)
6.21 ENTHESOPATHIA (A)

REHABILITATION
Program
L-0743
program: L-0743 enthesopathia (A)
Therapy parameters
Dosage: 20 J/cm2
Power: by probe
Frequency: Cont.
Probe
infrared
Effect
Note
Apply laser therapy as soon as possible when problems occur.

Part A.
(1051)
6.22 ENTHESOPATHIA (B)

REHABILITATION
Program
L-0715
program: L-0715 enthesopathia (B)
Therapy parameters
Dosage: 10 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
infrared
Effect
Note
Apply laser therapy as soon as possible after problems occur.

Part B.
(403)
6.23 EPICONDYLITIS (A)

REHABILITATION
Program
L-0716
program: L-0716 epicondylitis (A)
Therapy parameters
Dosage: 18 J/cm2
Power: by probe
Frequency: Cont.
Probe
infrared
2 - 3x a week
10 (min. 6)
Effect
Note
Combine continuous and pulse beam.

Part A.
(404)
6.24 EPICONDYLITIS (B)

REHABILITATION
Program
L-0717
program: L-0717 epicondylitis (B)
Therapy parameters
Dosage: 9 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
infrared
2 - 3x a week
10 (min. 6)
Effect
Note
Combine continuous and pulse beam.

Part B.
(405)
6.25 INDURATIO PENIS PLASTICA (A)

REHABILITATION
Program
L-0719
program: L-0719 induratio penis plastica (A)
Therapy parameters
Dosage: 20 J/cm2
Power: by probe
Frequency: Cont.
Probe
infrared
2 - 3x a week
min. 8 10
Effect
Note
First results occur after 5 or 6 therapy sessions. Irradiate not only indurated
places but also the whole penis. For excellent therapeutic effects combine
laser therapy with sonotherapy.
Part A.
(407)
6.26 INDURATIO PENIS PLASTICA (B)

REHABILITATION
Program
L-0720
program: L-0720 induratio penis plastica (B)
Therapy parameters
Dosage: 10 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
infrared
2 - 3x a week
min. 8 10
Effect
Note
First results occur after 5 or 6 therapy sessions. Irradiate not only indurated
places but also the whole penis. For excellent therapeutic effects combine
laser therapy with sonotherapy.
Part B.
(408)
6.27 ISCHIALGIA (A)

REHABILITATION
Program
L-0745
program: L-0745 ischialgia (A)
Therapy parameters
Dosage: 33 J/cm2
Power: by probe
Frequency: Cont.
Probe
infrared
8 - 15
Effect
analgesic, myorelaxation, vasodilatation
Note
Irradiate at location of ischialgia, L4 - L5 or L5 - S1. Use probe with the

greatest power, preferably cluster.
Part A.
(1053)
6.28 ISCHIALGIA (B)

REHABILITATION
Program
L-0721
program: L-0721 ischialgia (B)
Therapy parameters
Dosage: 17 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
infrared
8 - 15
Effect
Note
Irradiate at location of ischialgia, L4 - L5 or L5 - S1. Use probe with the

greatest power, preferably cluster.
Part B.
(409)
6.29 MORBUS DUPUYTREN (A)

REHABILITATION
Program
L-0722
program: L-0722 morbus Dupuytren (A)
Therapy parameters
Dosage: 18 J/cm2
Power: by probe
Frequency: Cont.
Probe
infrared
2 - 3x a week
min. 8 10
Effect
biostimulation, analgesic, vasodilatation
Note
First results occur after 5 or 6 therapy sessions. For excellent therapeutic

effects combine laser therapy with sonotherapy.
Part A.
(410)
6.30 MORBUS DUPUYTREN (B)

REHABILITATION
Program
L-0723
program: L-0723 morbus Dupuytren (B)
Therapy parameters
Dosage: 9 J/cm2
Power: by probe
Frequency: 5 Hz
Probe
infrared
2 - 3x a week
min. 8 10
Effect
biostimulation, analgesic, vasodilatation
Note
First results occur after 5 or 6 therapy sessions. For excellent therapeutic

effects combine laser therapy with sonotherapy.
Part B.
(411)
6.31 MYORELAXATIO (A)

REHABILITATION
Program
L-0746
program: L-0746 myorelaxatio (A)
Therapy parameters
Dosage: 18 J/cm2
Power: by probe
Frequency: Cont.
Probe
infrared
daily
8 (min. 2 - 3)
Effect
vasodilatation, analgesic, antiedematous
Note
Irradiate not only area of painful muscle but also respective trigger points.
Increase dose with increased depth of trigger point. Dose can reach up to 90
J/cm2.
Part A.
(1054)
6.32 MYORELAXATIO (B)

REHABILITATION
Program
L-0724
program: L-0724 myorelaxatio (B)
Therapy parameters
Dosage: 9 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
infrared
daily
8 (min. 2 - 3)
Effect
vasodilatation, analgesic, antiedematous
Note
Irradiate not only area of painful muscle but also respective trigger points.
Increase dose with increased depth of trigger point. Dose can reach up to 90
J/cm2.
Part B.
(412)
6.33 OEDEMA (A)

REHABILITATION
Program
L-0747
program: L-0747 oedema (A)
Therapy parameters
Dosage: 18 J/cm2
Power: by probe
Frequency: Cont.
Probe
infrared
3 - 5x a week
5 15
Effect
Note

Part A.
(1055)
6.34 OEDEMA (B)

REHABILITATION
Program
L-0725
program: L-0725 oedema (B)
Therapy parameters
Dosage: 9 J/cm2
Power: by probe
Frequency: 8 Hz
Probe
infrared
3 - 5x a week
5 15
Effect
Note

Part B.
(413)
6.35 SACRALGIA (A)

REHABILITATION
Program
L-0748
program: L-0748 sacralgia (A)
Therapy parameters
Dosage: 32 J/cm2
Power: by probe
Frequency: Cont.
Probe
infrared
3x per week
12 or until problems subside
Effect
analgesic, vasodilatation, myorelaxation
Note
Irradiate lumbo-sacral trocheal joints, from upper to lower spine, and the
same contralaterally to the sacro-iliac joint. Preferably use infrared cluster.
Part A.
(1056)
6.36 SACRALGIA (B)

REHABILITATION
Program
L-0726
program: L-0726 sacralgia (B)
Therapy parameters
Dosage: 16 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
infrared
3x per week
12 or until problems subside
Effect
Note
Irradiate lumbo-sacral trocheal joints, from upper to lower spine, and the
same contralaterally to the sacro-iliac joint. Preferably use infrared cluster.
Part B.
(414)
6.37 SPINA DORSALIS (DORSALGIA) (A)

REHABILITATION
Program
L-0749
program: L-0749 spina dorsalis (dorsalgia) (A)
Therapy parameters
Dosage: 32 J/cm2
Power: by probe
Frequency: Cont.
Probe
infrared
2 - 3x a week
6 12 (minimum of 5)
Effect
Note
Regarding extent of the area, use probe with the greatest power, preferably
infrared cluster.
Part A.
(1057)
6.38 SPINA DORSALIS (DORSALGIA) (B)

REHABILITATION
Program
L-0728
program: L-0728 spina dorsalis (dorsalgia) (B)
Therapy parameters
Dosage: 16 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
infrared
2 - 3x a week
6 12 (minimum of 5)
Effect
Note
Regarding the affected area it is recommended to use probe with the greatest
power, preferably infrared cluster.
Part B.
(416)
6.39 SPONDYLARTHRITIS ANCYLOPOETICA (A)

REHABILITATION
Program
L-0729
program: L-0729 spondylarthritis ancylopoetica (A)
Therapy parameters
Dosage: 20 J/cm2
Power: by probe
Frequency: Cont.
Probe
infrared
3 - 5x a week
68
Effect
Note
Acute pain: irradiate area of the affected joint.

Part A.
(417)
6.40 SPONDYLARTHRITIS ANCYLOPOETICA (B)

REHABILITATION
Program
L-0730
program: L-0730 spondylarthritis ancylopoetica (B)
Therapy parameters
Dosage: 10 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
infrared
3 - 5x a week
68
Effect
Note
Acute pain: irradiate area of the affected joint.

Part B.
(418)
6.41 SY. CANALI CARPI (A)

REHABILITATION
Program
L-0750
program: L-0750 sy. canali carpi (A)
Therapy parameters
Dosage: 10 J/cm2
Power: by probe
Frequency: Cont.
Probe
infrared
58
Effect
analgesic, vasodilatation
Note
Apply laser therapy in the initial stages of the condition. Can be combined
with magnetotherapy.
Part A.
(1058)
6.42 SY. CANALI CARPI (B)

REHABILITATION
Program
L-0731
program: L-0731 sy. canali carpi (B)
Therapy parameters
Dosage: 5 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
infrared
58
Effect
analgesic, vasodilatation
Note
Apply laser therapy in the initial stages of the condition. Combination with
magnetotherapy is beneficial.
Part B.
(419)
6.43 SY. TIETZE (A)

REHABILITATION
Program
L-0732
program: L-0732 sy. Tietze (A)
Therapy parameters
Dosage: 10 J/cm2
Power: by probe
Frequency: Cont.
Probe
infrared
2 - 3x a week
5 10
Effect
analgesic
Note
Laser therapy has an excellent clinical effect. If no satisfactory result is

present, increase dose up to 21 J/cm2.
Part A.
(420)
6.44 SY. TIETZE (B)

REHABILITATION
Program
L-0733
program: L-0733 sy. Tietze (B)
Therapy parameters
Dosage: 5 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
infrared
2 - 3x a week
5 10
Effect
analgesic
Note
Laser therapy has an excellent clinical effect. If no satisfactory result is

present, increase dose up to 21 J/cm2.
Part B.
(421)
6.45 SY. VERTEBRALIS (A)

REHABILITATION
Program
L-0751
program: L-0751 sy. vertebralis (A)
Therapy parameters
Dosage: 18 J/cm2
Power: by probe
Frequency: Cont.
Probe
infrared
2 - 3x a week
5 10 (or until problems significantly subside)
Effect
Note
Irradiate only the points where myogeloses occur (painful areas in muscles).
If no satisfactory result is observed, increase dose.
Part A.
(1059)
6.46 SY. VERTEBRALIS (B)

REHABILITATION
Program
L-0734
program: L-0734 sy. vertebralis (B)
Therapy parameters
Dosage: 9 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
infrared
2 - 3x a week
5 10 (or until problems are significantly reduced)
Effect
Note
Irradiate only the points where myogeloses occur. If no satisfactory result is

present, increase dose.
Part B.
(422)
6.47 TENDOPATHIA (A)

REHABILITATION
Program
L-0735
program: L-0735 tendopathia (A)
Therapy parameters
Dosage: 20 J/cm2
Power: by probe
Frequency: Cont.
Probe
infrared
2 - 3x a week
8 - 10 (min. 5)
Effect
Note
Similarly irradiate in postoperative states. After laser therapy pain and

oedema often rapidly subsides. However it is essential to instruct the patient
that the joint is not healed in minimum 6 weeks after problems occur and that
he must follow rest regime together with physiotherapy and eventually other
physical therapy.
Part A.
(423)
6.48 TENDOPATHIA (B)

REHABILITATION
Program
L-0736
program: L-0736 tendopathia (B)
Therapy parameters
Dosage: 10 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
infrared
2 - 3x a week
8 - 10 (min. 5)
Effect
Note

physical therapy.
Part B.
(424)
6.49 TENDOVAGINITIS (A)

REHABILITATION
Program
L-0737
program: L-0737 tendovaginitis (A)
Therapy parameters
Dosage: 20 J/cm2
Power: by probe
Frequency: Cont.
Probe
infrared
2 - 3x a week
8 - 10 (min. 5)
Effect
Note

that the joint is not healed in minimum 6 weeks after problems occur and
that he must follow rest regime together with physiotherapy and eventually
Part A.
(425)
6.50 TENDOVAGINITIS (B)

REHABILITATION
Program
L-0738
program: L-0738 tendovaginitis (B)
Therapy parameters
Dosage: 10 J/cm2
Power: by probe
Frequency: 10 Hz
Probe
infrared
2 - 3x a week
8 - 10 (min. 5)
Effect
Note

physical therapy.
Part B.
(426)
6.51 TINNITUS
REHABILITATION
Program
L-0740
program: L-0740 tinnitus
Therapy parameters
Dosage: 135 J/cm2

Power: by probe
Frequency: 5 Hz
Probe
infrared
2 - 3x a week
6 - 12
Effect
biostimulation
Note
Unusually high dose is needed for sufficient effect as 98% of irradiated

energy is absorbed in petrous bone! Apply to mastoid processus towards the
contralateral orbit. If auditory canal is irradiated directly, dose of 75 J/cm2 is
satisfactory. Combine treatment with manipulative therapy of the spine.
(975)

038-80laserdiag Selection English 602 PDF

Încărcat de

Informații document

Titlu original

Drepturi de autor

Formate disponibile

Partajați acest document

Partajați sau inserați document

Opțiuni de partajare

Vi se pare util acest document?

Este necorespunzător acest conținut?

Drepturi de autor:

Formate disponibile

038-80laserdiag Selection English 602 PDF

Încărcat de

Drepturi de autor:

Formate disponibile

Laser Therapy

BTL THERAPEUTIC ENCYCLOPAEDIA

LASER THERAPY- BTL THERAPEUTIC ENCYCLOP AEDI A | P AGE 2 OF 176

LASER THERAPY- BTL THERAPEUTIC ENCYCLOP AEDI A | P AGE 3 OF 176

LASER THERAPY- BTL THERAPEUTIC ENCYCLOP AEDI A | P AGE 4 OF 176

spondylarthritis ancylopoetica (A) ............................................................................................... 164

LASER THERAPY- BTL THERAPEUTIC ENCYCLOP AEDI A | P AGE 5 OF 176

according to power of the probe

LASER THERAPY- BTL THERAPEUTIC ENCYCLOP AEDI A | P AGE 6 OF 176

1.2 ANALGIA - HAEMATOMA (EXTRAORALIS)

analgesic, antiedematous, vasodilatation

LASER THERAPY- BTL THERAPEUTIC ENCYCLOP AEDI A | P AGE 7 OF 176

1.3 ANALGIA - HAEMATOMA (INTRAORALIS)

analgesic, antiedematous, vasodilatation

LASER THERAPY- BTL THERAPEUTIC ENCYCLOP AEDI A | P AGE 8 OF 176

1.4 ANALGIA - INJURED NERVE

according to power of the probe

LASER THERAPY- BTL THERAPEUTIC ENCYCLOP AEDI A | P AGE 9 OF 176

1.5 ANGULUS INFECTIOSUS

according to power of the probe

preferably daily, minimum 3 times a week

Irradiate the affected area.

LASER THERAPY- BTL THERAPEUTIC ENCYCLOP AEDI A | P AGE 10 OF 176

1.6 APHTA (STOMATITIS APHTOSA) (A)

according to power of the probe

3 - 5 (2x per day possible)

Irradiate the entire affected surface.

LASER THERAPY- BTL THERAPEUTIC ENCYCLOP AEDI A | P AGE 11 OF 176

1.7 APHTA (STOMATITIS APHTOSA) (B)

according to power of the probe

3 - 5 (2x per day possible)

Irradiate the entire affected surface.

LASER THERAPY- BTL THERAPEUTIC ENCYCLOP AEDI A | P AGE 12 OF 176

1.8 CARIES DENTIS

according to power of the probe

LASER THERAPY- BTL THERAPEUTIC ENCYCLOP AEDI A | P AGE 13 OF 176

1.9 CICATRIX CHELOIDUM (A)

according to power of the probe and size of scar

biostimulation, vasodilatation, stimulation of collagen production, increased

LASER THERAPY- BTL THERAPEUTIC ENCYCLOP AEDI A | P AGE 14 OF 176

1.10 CICATRIX CHELOIDUM (B)

according to power of the probe and size of scar

biostimulation, vasodilatation, stimulation of collagen production, increased

LASER THERAPY- BTL THERAPEUTIC ENCYCLOP AEDI A | P AGE 15 OF 176

1.11 CICATRIX RECENS (A)

according to power of the probe and size of scar

daily - 3x per week

biostimulation, vasodilatation, stimulation of collagen production, increased

LASER THERAPY- BTL THERAPEUTIC ENCYCLOP AEDI A | P AGE 16 OF 176

1.12 CICATRIX RECENS (B)

according to power of the probe and size of scar

daily - 3x per week

biostimulation, vasodilatation, stimulation of collagen production, increased

LASER THERAPY- BTL THERAPEUTIC ENCYCLOP AEDI A | P AGE 17 OF 176

according to power of the probe

Contusion is accompanied by a limitation of mouth opening and swelling

LASER THERAPY- BTL THERAPEUTIC ENCYCLOP AEDI A | P AGE 18 OF 176

according to power of the probe

depending on reaction of the treated tissue and depth of necrosis 1 - 5

biostimulation, antiphlogistic, supports granulation, analgesic

In chronic diseases frequent, preferably daily irradiation can not be avoided.

LASER THERAPY- BTL THERAPEUTIC ENCYCLOP AEDI A | P AGE 19 OF 176

1.15 DENTITIO DIFFICILIS-ANALGIA